Elevance Health, Inc. Cash & Equivalents 2006-2025 | ELV
What is cash & equivalents?
Cash and cash equivalents can be defined as the most liquid assets on a company's balance sheet, including cash on hand and short-term investments maturing within 90 days.
What is Elevance Health, Inc.'s current cash & equivalents?
Elevance Health, Inc. (ELV) annual cash & equivalents for 2025 was $9.49B, a 14.51% increase from 2024. Elevance Health, Inc. cash & equivalents for the quarter ending December 31, 2025 was $9.49B.
What was Elevance Health, Inc.'s cash & equivalents in 2024?
Elevance Health, Inc. annual cash & equivalents for 2024 was $8.29B, a 27.00% increase from 2023.
What was Elevance Health, Inc.'s cash & equivalents in 2023?
Elevance Health, Inc. annual cash & equivalents for 2023 was $6.53B, a 11.66% decline from 2022.
What is Elevance Health, Inc.'s 5-year cash & equivalents CAGR?
Elevance Health, Inc. cash & equivalents grew at a compound annual growth rate (CAGR) of 10.58% from FY2020 to FY2025, going from $5.74B to $9.49B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $9.49B | +14.5% | 10-K |
| FY2024 | $8.29B | +27.0% | 10-K |
| FY2023 | $6.53B | -11.7% | 10-K |
| FY2022 | $7.39B | +51.4% | 10-K |
| FY2021 | $4.88B | -15.0% | 10-K |
| FY2020 | $5.74B | +16.3% | 10-K |
| FY2019 | $4.94B | +25.5% | 10-K |
| FY2018 | $3.93B | +9.0% | 10-K |
| FY2017 | $3.61B | -11.4% | 10-K |
| FY2016 | $4.08B | +92.9% | 10-K |
| FY2015 | $2.11B | -1.8% | 10-K |
| FY2014 | $2.15B | +36.0% | 10-K |
| FY2013 | $1.58B | -36.1% | 10-K |
| FY2012 | $2.48B | +12.4% | 10-K |
| FY2011 | $2.20B | +23.1% | 10-K |
| FY2010 | $1.79B | -62.9% | 10-K |
| FY2009 | $4.82B | +120.5% | 10-K |
| FY2008 | $2.18B | -21.1% | 10-K |
| FY2007 | $2.77B | +6.4% | 10-K |
| FY2006 | $2.60B | - | 10-K |